The Limited Times

Now you can see non-English news...

Patent litigation: Curevac is suing Biontech for a corona vaccine

2022-07-05T11:59:25.355Z

The Tübingen biotech company Curevac sees its patents being infringed by its competitor Biontech. That is why it has now sued the competition from Mainz, which was significantly more successful in the corona pandemic.



Enlarge image

Curevac's first corona vaccine project failed

Photo: Martin Wagner / IMAGO

The biotech company Curevac has sued the vaccine manufacturer Biontech before the Düsseldorf Regional Court.

The company from Tübingen sees its patents being infringed by the competitor from Mainz, which was successful in the pandemic.

The lawsuit is directed against Biontech and two subsidiaries, Curevac announced.

Accordingly, “fair compensation” is required for the violation of a number of its intellectual property rights, which were used in the manufacture and sale of the Covid 19 vaccine Comirnaty by Biontech and its US partner Pfizer.

However, the Tübingen-based company emphasized that it is not planning any injunctions that could impede the production, sale or distribution of Comirnaty.

More soon on SPIEGEL.de

Apr/Reuters

Source: spiegel

All business articles on 2022-07-05

Similar news:

You may like

News/Politics 2022-07-05T14:11:08.555Z
News/Politics 2022-07-05T12:46:54.725Z
Business 2022-07-05T14:05:29.092Z

Trends 24h

Business 2022-08-07T18:07:17.458Z
Business 2022-08-07T13:55:56.931Z

Latest

© Communities 2019 - Privacy